{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Perspectives on Proteomics and Cancer
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide an overview of proteomics in cancer research and therapy.Learning Objectives
After completing this continuing education activity you will be able to:
- Assess recent advances in proteomics technology.
- Evaluate the clinical significance of proteomics for the evolution of cancer research, diagnosis, and treatment.
Disclosures
The author(s), faculty, staff, and planners, including spouses/partners (if any), in any position to control the content of this activity, have disclosed that they have no financial relationships with, or financial interests in, any commercial companies relevant to this educational activity.
Price:
$12.95
Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: OT1020
Published: October 2020
Expires: 12/6/2024
Sources:
Oncology Times
Required Passing Score: 8/10 (80%)
Specialties:
Oncology
Topics:
Proteomics